T1	Participants 14 35	hypertensive patients
T2	Participants 81 100	in a rural setting.
T3	Participants 193 292	patients who were monitored by specially trained community pharmacists in a group medical practice.
T4	Participants 531 542	25 patients
T5	Participants 581 609	control group of 26 patients
